PRONEXUS INC. FY2026 FY Earnings Report

Quick View

Executive Summary

For the fiscal year ended March 2026, revenue was ¥328.2B (vs. prior year +¥18.3B, +5.9%), operating income was ¥29.1B (vs. prior year +¥27.0B, +1,290.8%), Ordinary Income was ¥19.0B (vs. prior year -¥3.4B, -15.1%), and net income attributable to owners of the parent was ¥21.1B (vs. prior year +¥16.6B, +367.5%). The rebound from the prior year's large impairment and other expenses drove a significant improvement in operating-stage profitability, resulting in final profit growing more than fourfold. Revenue continued a three-year streak of growth, and operating margin normalized to 8.9% (prior year 0.7%). Solid disclosure-related demand and normalization of expenses led the profit recovery, while M&A investments (goodwill +¥18.9B) and intangible investments (¥17.9B) signal a push to accelerate growth. Operating Cash Flow (OCF) was ¥35.3B, 1.6x net income, indicating high earnings quality, but Investing CF was -¥37.2B leaving Free Cash Flow (FCF) at -¥1.9B. Total shareholder returns amounted to ¥21.7B (dividends ¥11.7B + share buybacks ¥10.0B), yielding a Total Return Ratio of 103%, exceeding net income. Equity ratio was 63.0% and the company is effectively debt-free (interest-bearing debt ¥0.8B), so the balance sheet is robust, but management of a high short-term liability ratio (71%) and lease liabilities of ¥23.1B is important.

Drivers of Performance

[Revenue] Revenue grew steadily to ¥328.2B (+5.9% YoY). By product, disclosure-related services for listed companies were ¥140.7B (prior year ¥124.5B, +13.0%) and led growth with double-digit increases; listed-company IR & events related were also robust at ¥109.2B (prior year ¥106.6B, +2.4%). Financial-product disclosure-related revenue was ¥67.3B (prior year ¥68.5B, -1.7%), and database-related revenue was ¥11.0B (prior year ¥10.4B, +5.5%). As a single segment (Disclosure-related Business), disclosure needs from domestic listed companies supported steady demand for IPO-related and IR support services. External tailwinds included active capital markets and increased complexity of disclosure regulations, producing favorable order conditions. Contract liabilities (advance receipts) were ¥7.8B (prior year ¥7.6B), essentially flat, indicating a stable short-term order backlog.

[Profitability] Cost of sales was ¥205.3B (prior year ¥198.1B, +3.6%), improving gross margin to 37.4% (prior year 36.1%) up 1.3pt. SG&A was ¥93.6B (prior year ¥85.4B, +9.6%), raising the SG&A ratio to 28.5% (prior year 27.6%) up 0.9pt, driven by higher personnel and development costs and M&A integration expenses. Operating income was ¥29.1B (prior year ¥2.1B), taking operating margin to 8.9% (prior year 0.7%) with a dramatic improvement. This improvement mainly reflects that prior-year “other expenses” of ¥25.4B (including impairments of ¥25.2B) dropped sharply to ¥1.3B this period (-95.0%), so normalization of expenses was the biggest factor. Net finance income was ¥1.3B (prior year ¥0.8B) less finance costs ¥0.3B (prior year ¥0.1B), producing Ordinary Income of ¥19.0B (prior year ¥22.4B, -15.1%). The decline at the ordinary-income level reflects the absence this year of prior-year equity-method investment disposal gains of ¥14.1B. Pre-tax Profit was ¥30.1B (prior year ¥16.8B, +79.1%); after corporate taxes of ¥8.5B (effective tax rate 28.2%), net income was ¥21.6B (prior year ¥4.6B, +372.9%). Net income attributable to owners of the parent was ¥21.1B (prior year ¥4.5B, +367.5%), improving net margin to 6.4% (prior year 1.5%) up 4.9pt. Special items were limited (impairment this period ¥0.6B only), indicating a return to earnings on an ordinary basis. In conclusion, the company achieved both revenue and profit growth, with the elimination of one-off expenses normalizing margins.

Key Financial Metrics

[Profitability] ROE was 8.7%, up 6.9pt from 1.8% last year, materially exceeding the company’s historical performance. DuPont decomposition (net margin 6.4% × total asset turnover 0.88x × financial leverage 1.54x) shows that net margin improvement was the main driver. Operating margin of 8.9% improved 8.2pt from 0.7%, explained by the spread between gross margin 37.4% (prior year 36.1%) and SG&A ratio 28.5% (prior year 27.6%). The rise in SG&A ratio reflects growth investments and M&A integration costs, but the rebound from prior-year impairment/other expenses (total approx. ¥25.4B) normalized operating-stage profitability. [Cash Quality] OCF ¥35.3B is 1.6x net income ¥21.6B, showing solid cash backing of earnings. OCF/EBITDA ratio is 0.62x (EBITDA ≒ ¥56.9B, operating income ¥29.1B + depreciation & amortization ¥27.9B), relatively low, with corporate tax payments ¥18.1B and lease payments ¥9.3B pressuring cash. [Investment Efficiency] Total asset turnover improved to 0.88x (prior year 0.80x). Goodwill rose sharply to ¥30.6B (prior year ¥11.7B, +162%), and intangible-asset ratio rose to 13.9% of total assets (prior year 12.7%). This reflects growth investment via M&A, but as goodwill is non-amortizing under IFRS, impairment-test sensitivity has increased. [Leverage & Solvency] Equity ratio 63.0% (prior year 64.6%) remains stable. Interest-bearing debt was ¥0.8B (prior period ¥3.5B, -77.7%), effectively net cash, and interest coverage ≒ 115x (operating income / finance costs) is extremely strong. Current ratio was 189% (current assets ¥141.2B / current liabilities ¥74.5B), indicating healthy short-term payment capacity, but the short-term liability ratio is high at 71% (current liabilities / total liabilities), requiring management of lease-related current liabilities ¥10.0B and other current liabilities ¥37.9B during the period.

Cash Flow Analysis

Operating CF was ¥35.3B (prior year ¥42.9B, -17.7%), securing 1.6x net income of ¥21.6B. Pre-working-capital subtotal was ¥52.4B, with accounts receivable increase -¥1.6B, accounts payable decrease -¥5.2B, inventories decrease +¥0.1B, and consumption tax payable increase +¥1.7B impacting cash. Corporate tax payments ¥18.1B and lease payments ¥9.3B were major outflows. Investing CF was -¥37.2B (prior year +¥6.0B), a large outflow comprised of capital expenditure -¥9.1B, intangible asset acquisitions -¥17.9B, investment acquisitions -¥8.0B, investment disposals +¥12.1B, and subsidiary acquisitions -¥14.4B. This reflects an acceleration of growth strategy through M&A and intangible investment. Financing CF was -¥34.0B (prior year -¥20.1B), driven by long-term loan repayments -¥3.0B, lease liability repayments -¥9.3B, share buybacks -¥10.0B, and dividend payments -¥11.7B. Free Cash Flow was OCF ¥35.3B + Investing CF -¥37.2B = -¥1.9B, turning negative. Cash and equivalents at period-end were ¥87.4B (prior year ¥123.1B, -¥35.7B), reflecting total returns ¥21.7B and cash outflows for M&A/investments. The decrease in accounts payable and increase in accounts receivable suggest a temporary working-capital deterioration, but signs of manipulation are limited.

Earnings Quality

Of the period’s net income ¥21.6B, ordinary items were the primary contributors; the prior-year equity-method investment disposal gain of ¥14.1B did not recur. Conversely, prior-year impairments ¥25.2B and other expenses ¥25.4B contracted sharply to impairment ¥0.6B and other expenses ¥1.3B this period, normalizing earnings quality. Non-operating income was small (finance income ¥1.3B, 0.4% of sales), indicating low dependency. OCF / net income was 1.6x, reflecting high accrual quality and good cash backing. However, OCF/EBITDA at 0.62x is low, with corporate tax payments ¥18.1B (≈60% of pre-tax profit ¥30.1B) and lease payments ¥9.3B pressuring cash. The inversion between Ordinary Income ¥19.0B and net income ¥21.6B reflects the non-recurrence of prior equity-method gains at the ordinary level and a temporary reduction in pre-tax one-off expenses that boosted net income. One-off items were minor (impairment ¥0.6B), supporting earnings recognition based on core profitability. Comprehensive income was ¥23.7B, ¥2.1B higher than net income ¥21.6B; other comprehensive income comprised valuation gains on other financial assets ¥0.7B, remeasurements of defined benefit plans ¥0.9B, and foreign currency translation adjustments ¥0.5B, so the impact on capital quality is limited.

Forecasts & Guidance

Against the full-year guidance (Revenue ¥340.0B, Operating Income ¥30.0B, Net Income Attributable to Parent ¥20.5B), actual performance was Revenue ¥328.2B (progress 96.5%), Operating Income ¥29.1B (97.0%), and Net Income Attributable to Parent ¥21.1B (102.9%). Revenue and operating income slightly missed guidance, while final profit exceeded expectations. Upside factors included a larger-than-assumed reduction in other expenses and increased finance income. Shortfalls were driven by delayed revenue recognition timing in Q4 and higher SG&A. Actual EPS was ¥83.19 versus guidance ¥81.12, a 2.6% beat. Dividend guidance ¥22.00 was exceeded by actual annual dividend ¥42.00 (interim ¥20 + year-end ¥22), with interim including a ¥2 commemorative dividend for the 95th anniversary, making the effective base ¥40. Guidance achievement was generally sound and underlying assumptions were validated. Contract liabilities ¥7.8B suggest recognized revenue opportunities for the next fiscal year, and realization of intangible investment and M&A effects is expected to be the next period’s growth driver.

Shareholder Returns

Dividends were annual ¥42.00 (interim ¥20, year-end ¥22), with a payout ratio of 55.2% (based on basic EPS ¥83.19). The interim included a ¥2 commemorative dividend for the 95th anniversary, making the effective annual base ¥40. Prior year dividend was ¥26 (including a special dividend ¥16); excluding the special dividend the regular dividend was ¥10, so effective regular dividend rose materially to ¥40 this period. Dividend policy is profit-linked and payout ratio sits within industry-standard ranges. Share buybacks of ¥10.0B were executed, acquiring 3.1 million shares (approximately 12.2% of the average shares outstanding of 25.3 million during the period) to improve capital efficiency. Total returns totaled dividends ¥11.7B + buybacks ¥10.0B = ¥21.7B, giving a Total Return Ratio of 103% relative to net income attributable to owners of the parent ¥21.1B. Because FCF was -¥1.9B this period, total returns were funded from on-hand cash and investment disposal proceeds (¥12.1B). With cash equivalents ¥87.4B and OCF ¥35.3B, short-term sustainability of dividends and returns is supported, but the ability to sustain both M&A/intangible investment pace and high total returns will depend on future investment priorities. Mid-term policy is expected to prioritize growth investment while adjusting total returns flexibly according to profit levels.

Risk Factors

1. Demand sensitivity to economic conditions: Approximately 75% of revenue is disclosure/IR related to listed companies, so a stagnant capital market or reduced IPO activity could weaken demand. Financial-product disclosure has already declined -1.7% YoY, embedding downside risk in an economic downturn. The single-segment structure limits diversification benefits.

2. M&A integration and goodwill impairment risk: Goodwill surged to ¥30.6B (8.2% of total assets, 12.6% of net assets) with ¥14.4B spent on subsidiary acquisitions. Under IFRS non-amortization, future impairment tests could cause earnings volatility. Delays in realizing acquisition synergies or shortfalls in revenue plans increase the likelihood of impairment charges. The company has precedent of recording impairments ¥25.2B in the prior year, warranting monitoring.

3. Heavy short-term liabilities and liquidity risk: Short-term liability ratio is 71% with current portion of lease liabilities ¥10.0B and other current liabilities ¥37.9B concentrating intraperiod cash needs. While OCF is ample, corporate tax payments ¥18.1B and lease payments ¥9.3B require careful intraperiod working-capital timing management. Additionally, non-current other financial liabilities ¥15.4B (including non-controlling-interest-related forward contracts) carry uncertainty around future cash outflows.

Industry Benchmarks (reference — company analysis)

Profitability & Returns

Profitability metrics exceed manufacturing medians, indicating a favorable industry position.

Growth & Capital Efficiency

Revenue growth outpaces the median by 2.2pt, exceeding industry-average growth pace.

※ Source: Company compilation

Key Points from the Financial Results

1. Normalization of margins and ROE recovery: The rebound from prior-year large impairment and other expenses (total approx. ¥25.4B) drove operating margin to 8.9% (prior year 0.7%), net margin to 6.4% (prior year 1.5%), and ROE to 8.7% (prior year 1.8%), a dramatic improvement. Expense normalization is expected to continue and core profitability has returned to levels above industry medians. The SG&A ratio increase (+0.9pt) reflects growth investment, but SG&A growth (+9.6%) outpaced revenue growth (+5.9%), a point to watch as it will affect operating leverage next period.

2. Growth acceleration via M&A and intangible investment: Goodwill increased by +¥18.9B (+162%), intangible asset acquisitions ¥17.9B, and subsidiary acquisitions ¥14.4B signal active growth investment. The company is reinforcing competitive advantage in disclosure-related single-segment operations while expanding into adjacent areas such as database services and IR/events. Contract liabilities ¥7.8B indicate revenue stability and a favorable short-term order environment. While goodwill increases entail impairment risk, current integration is in early stages and realized risk is limited at this time.

3. Balance between cash generation and total returns: OCF ¥35.3B is 1.6x net income, but investing CF -¥37.2B produced FCF -¥1.9B. Total returns ¥21.7B (Total Return Ratio 103%) exceeded net income, showing an active stance to balance growth investment and shareholder returns. With cash ¥87.4B and effectively no net debt, financial flexibility is high and short-term sustainability of returns is supported. Mid-term sustainability of total returns will depend on M&A/intangible investment pace and improvement in OCF/EBITDA. Management of lease liabilities ¥23.1B and non-current other financial liabilities ¥15.4B will determine future cash demands.

---

This report was automatically generated by AI analyzing XBRL financial statement data and is an earnings analysis document. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are based on publicly disclosed financial statements compiled by the company for reference. Investment decisions are your own responsibility; please consult a professional advisor as necessary.